A successful antibiotic treatment by a new administration route: a case report of a subcutaneous administration of ceftazidime and tobramycin.
ceftazidime
subcutaneous administration
tobramycin
Journal
Fundamental & clinical pharmacology
ISSN: 1472-8206
Titre abrégé: Fundam Clin Pharmacol
Pays: England
ID NLM: 8710411
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
21
02
2019
revised:
13
04
2019
accepted:
25
04
2019
pubmed:
1
5
2019
medline:
14
4
2020
entrez:
1
5
2019
Statut:
ppublish
Résumé
When intramuscular or intravenous administrations of parenteral drugs are not possible, the use of other routes (e.g., subcutaneous route) should be considered. We report a patient with Duchenne muscular dystrophy, who was hospitalized for acute pneumonia due to antibiotic-resistant strains of bacteria. Our patient was successfully recovered with antimicrobial therapy by subcutaneous administration of ceftazidime and tobramycin, for which no safety and efficacy data are available in humans. To the best of our knowledge, this case is the first supporting the subcutaneous administration safety and potential efficacy of both ceftazidime and tobramycin in humans.
Substances chimiques
Anti-Bacterial Agents
0
Ceftazidime
9M416Z9QNR
Tobramycin
VZ8RRZ51VK
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
703-706Informations de copyright
© 2019 Société Française de Pharmacologie et de Thérapeutique.
Références
Champoux N., Du Souich P., Ravaoarinoro M., Phaneuf D., Latour J., Cusson J.R. Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers. Br. J. Clin. Pharmacol. (1996) 42 325-331.
Forestier E., Paccalin M., Roubaud-Baudron C., Fraisse T., Gavazzi G., Gaillat J. Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks. Clin. Microbiol. Infect. (2015) 21 370.
Roubaud-Baudron C., Forestier E., Fraisse T. et al. Tolerance of subcutaneously administered antibiotics: a French national prospective study. Age Ageing (2017) 46 151-155.
Robelet A., Caruba T., Corvol A. et al. Antibiotics given subcutaneously to elderly. Presse Med. (2009) 38 366-376.
Wood C.A., Norton D.R., Kohlhepp S.J. et al. The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J. Infect. Dis. (1988) 158 13-22.
Monfrinotti A., Ambros L., Prados A.P., Kreil V., Rebuelto M. Pharmacokinetics of ceftazidime after intravenous, intramuscular and subcutaneous administration to dogs. J. Vet. Pharmacol. Ther. (2010) 33 204-207.
Ebihara T., Oshima S., Okita M. et al. Absorption kinetics of subcutaneously administered ceftazidime in hypoperfused guinea pigs. Curr. Ther. Res. Clin. Exp. (2014) 18 7-13.
Berkhout J., Melchers M.J., van Mil A.C. et al. Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice. Antimicrob. Agents Chemother. (2015) 59 2299-2304.
Rule R., Rubio M., Perelli M.C. Pharmacokinetics of ceftazidime in sheep and its penetration into tissue and peritoneal fluids. Res. Vet. Sci. (1991) 51 233-238.
Augey F., Allombert-Blaise C., Paret N. Nécroses cutanées étendues après administration sous-cutanée de ceftriaxone. Ann. Dermatol. Vénéréol. (2014) 141 S499.
Ebihara T., Oshima S., Yasuda Y. et al. A survey of subcutaneous blood flow in patients with SMID and subcutaneous ceftazidime administration using mentholated warm compresses in healthy subjects. J. Int. Med. Res. (2016) 44 248-257.